Categories AlphaGraphs, Technology

E3 2018: Microsoft announces Xbox upgrade, game-streaming service

Though primarily a show-off gala for game developers, this year’s Electronic Entertainment Expo (E3 2018) witnessed some interesting updates from Microsoft (MSFT), including an announcement that they are building a successor to Xbox One X. Meanwhile, rumors are making rounds that the tech giant will also announce a cheaper version of its Surface tablet.

Sending Xbox fans gung-ho, Microsoft unveiled 52 games at the E3 conference on Sunday, including 18 exclusive ones. The exclusive titles include major new iterations of Halo, Gears of War, and racing video game Forza Horizon 4. Other major titles announced at the gaming expo include Kingdom Hearts 3, Battlefield V, Fallout 76 and Devil May Cry 5.

Besides these, the Windows-maker said it would soon form a brand-new studio called The Initiative, by acquiring four content studios – Undead Labs, Compulsion Labs, PlayGround Games and Ninja Theory.

Microsoft Gaming Revenue Growth Trend

Netflix of gamers

Microsoft officially announced its plans to launch a game-streaming service that lets users play games online without the need for a disc. AlphaStreet had earlier reported on Microsoft’s intention to create a Netflix-model gaming service to fend off competition from Sony (SNE). Sony has a PlayStation Now streaming service at $19.99 a month.

In the recently completed third-quarter, Microsoft’s gaming revenue climbed 18% to $2.3 billion and its Xbox Live monthly active users grew 13% to 59 million.

Microsoft Xbox Live Monthly Active Users

It is expected that Microsoft will soon bring out a cheaper Surface tablet in the second half of 2018, to compete with Apple’s (AAPL) iPad. The new tablet is predicted to have a 10-inch screen, round edges and USB-C connectivity, and is expected to be 20% lighter than high-end models. It will feature Intel (INTC) processor and graphics chips, 64 or 128 GB storage models, Windows 10 Pro, LTE network, and will be priced at around $400, according to market observers.

Most Popular

Context Therapeutics: Another clinical-stage oncology research firm to go public soon

The US primary markets seem to be having a record-breaking start to the year, with over $171 billion raised in the first half of 2021 compared to $168 billion for

Biogen (BIIB) Stock: Does FDA nod for Aduhelm offer a buying opportunity?

The pharmaceutical industry has been witnessing hectic activity for some time, with most drug makers either channelizing their resources for vaccine development or engaging in COVID care programs. Biotechnology giant

IPO News: Monte Rosa Therapeutics will go public this week, here are a few things to know

Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a healthy pace. The global biotechnology market is estimated

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top